Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosisYvonne L. Latour, Cynthia J. Tifft, María L. Allende et al.|Molecular Genetics and Metabolism Reports|2019Cited by 58
Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patientsElena‐Raluca Nicoli, Cynthia J. Tifft, Mylene Huebecker et al.|Molecular Genetics and Metabolism|2023Cited by 7
Targeting GLB1 in mice by CRISPR/Cas9 genome editing: Establishing a novel model for type II GM1 gangliosidosisElena‐Raluca Nicoli, Cynthia J. Tifft, Robin Yoon et al.|Molecular Genetics and Metabolism|2020Cited by 0